---
DrugClass: "[[Antihypertensive Drugs]]"
SubClass: "[[Calcium channel blockers]]"
DrugClassContra: "[[Antihypertensive Drugs#Contraindications]]"
DrugClassAdverse: "[[Antihypertensive Drugs#Side/Adverse Effects]]"
SecondaryDrugClass: "[[Antianginal and Vasodilating Drugs]]"
SecondarySubClass: "[[Calcium Channel Blockers Used for Anginal Issues]]"
SecondaryAdverse: "[[Antianginal and Vasodilating Drugs#Side/Adverse Effects]]"
SecondaryContra: "[[Antianginal and Vasodilating Drugs#Contraindications]]"
ThirdDrugClass: "[[Cardiotonic and Antiarrhythmic Drugs]]"
ThirdSubClass: "[[Antiarrhythmics]]"
BrandName: Calan SR, Verelan
Chapter: "33"
KindleLinkChap: "[Chapter 33](kindle://book?action=open&asin=B09FRF11YJ&location=17954)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
aliases: 
ThirdAdverse: "[[Antiarrhythmics#Adverse Reactions]]"
ThirdContra: "[[Antiarrhythmics#Contraindications]]"
---
```smiles
CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`
`= this.SecondaryDrugClass`
	`= this.SecondaryDrugClass.KindleLinkChap`
`= this.ThirdDrugClass`
	`= this.ThirdDrugClass.KindleLinkChap`
	
### Dosage & Usage
Hypertension, chronic stable angina, [[vasospastic angina]], chronic atrial flutter, paroxysmal superventricular tachycardia
Individualize dosage; do not exceed 480 mg/ day orally in divided doses 
Sustained release: 120– 180 mg/ day orally; maximum dose, 480 mg 
Extended release: 120– 180 mg/ day orally, maximum dose, 480 mg/ day

### Contraindications
See `= this.DrugClassContra`
See `= this.SecondaryContra`
See `= this.ThirdContra`

### Interactionsrse Effects
See `= this.DrugClassAdverse`
See `= this.SecondaryAdverse`
See `= this.ThirdAdverse`
Headache, constipation 

### Interactions

`= this.ChemLink+this.file.name`

